These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8994216

  • 21. Use of antisense oligodeoxynucleotide to delta-opioid receptor mRNA in the study of turnover of delta-opioid receptors in the spinal cord of the mouse.
    Narita M, Mizoguchi H, Nagase H, Tseng LF.
    Psychopharmacology (Berl); 1997 Oct; 133(4):347-50. PubMed ID: 9372533
    [Abstract] [Full Text] [Related]

  • 22. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
    Tseng LF, Collins KA, Kampine JP.
    Eur J Pharmacol; 1994 Jun 02; 258(1-2):R1-3. PubMed ID: 7925585
    [Abstract] [Full Text] [Related]

  • 23. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.
    Negri L, Lattanzi R, Borsodi A, Toth G, Salvadori S.
    Antisense Nucleic Acid Drug Dev; 1999 Apr 02; 9(2):203-11. PubMed ID: 10355826
    [Abstract] [Full Text] [Related]

  • 24. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
    Lai J, Bilsky EJ, Rothman RB, Porreca F.
    Neuroreport; 1994 May 09; 5(9):1049-52. PubMed ID: 8080957
    [Abstract] [Full Text] [Related]

  • 25. Receptor-selective antagonism of opioid antinociception in female versus male rats.
    Craft RM, Tseng AH, McNiel DM, Furness MS, Rice KC.
    Behav Pharmacol; 2001 Dec 09; 12(8):591-602. PubMed ID: 11856896
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide.
    Tseng LF, Narita M, Kampine JP.
    Eur J Pharmacol; 1995 Dec 12; 287(2):169-72. PubMed ID: 8749031
    [Abstract] [Full Text] [Related]

  • 32. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T, Takemori AE, Sultana M, Portoghese PS, Mosberg HI, Hruby VJ, Haaseth RC, Matsunaga TO, Porreca F.
    Eur J Pharmacol; 1994 Feb 03; 252(2):133-7. PubMed ID: 8157053
    [Abstract] [Full Text] [Related]

  • 33. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
    Kakinohana M, Nakamura S, Fuchigami T, Davison KJ, Marsala M, Sugahara K.
    Br J Anaesth; 2006 Jan 03; 96(1):88-94. PubMed ID: 16317029
    [Abstract] [Full Text] [Related]

  • 34. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X, Geller EB, Adler MW.
    Eur J Pharmacol; 2007 Feb 14; 557(1):32-6. PubMed ID: 17173891
    [Abstract] [Full Text] [Related]

  • 35. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 14; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L, Noviello L, Noviello V.
    Eur J Pharmacol; 1996 Jan 18; 296(1):9-16. PubMed ID: 8720471
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.